Duke-Margolis: In the News

Susan Dentzer Appointed Visiting Fellow

The Duke-Margolis Center for Health Policy has appointed Susan Dentzer as a Visiting Fellow. Dentzer has been involved with the Center since its beginning as a member of the Duke-Margolis Advisory Board. As a Visiting Fellow, she will take on a larger role in supporting and contributing to the...

The Duke-Margolis Center for Health Policy has appointed Susan Dentzer as a Visiting Fellow. Dentzer...

Market Entry Rewards within the Broader Incentive Landscape

As part of a multifactorial approach to address weak incentives for innovative antimicrobial drug development, market entry rewards (MERs) are an emerging solution. Recently, the Duke-Margolis Center for Health Policy released the Priority Antimicrobial Value and Entry (PAVE) Award proposal, which...

As part of a multifactorial approach to address weak incentives for innovative antimicrobial drug...

A Preferable Path For Thwarting Pharmaceutical Product Hopping

The recently announced White House blueprint to curb the high cost of pharmaceuticals addresses a policy problem that both ranks near the top of consumers’ health care concerns, and is a leading reason why US healthcare spending is the highest among OECD nations. Many critics attribute significant...

The recently announced White House blueprint to curb the high cost of pharmaceuticals addresses a...